腫瘤消融市場規模、佔有率和成長分析（按消融類型、手術類型、應用、最終用戶和地區分類）－2026-2033年產業預測

全球腫瘤消融市場規模預計在 2024 年達到 15 億美元，從 2025 年的 17 億美元成長到 2033 年的 47.2 億美元，在預測期（2026-2033 年）內複合年成長率為 13.6%。

全球癌症消融市場正經歷強勁成長，這主要得益於癌症發生率的顯著上升，尤其是在低收入國家，同時，人們對更安全治療方法的需求也在不斷成長。預計高所得地區的癌症發生率將成長41%，而新興市場的新增癌症病例數可能成長超過80%。這一成長得益於多種治療方法的出現以及人們對微創和非侵入性治療的偏好。外科醫生和患者擴大選擇先進的腫瘤消融技術，認為其具有恢復更快、患者舒適度更高等優勢，並逐漸拋棄傳統治療方法。此外，與先進腫瘤消融技術相關的門診手術不僅成為治療小型腫瘤的首選方案，而且透過將年度癌症篩檢率與手術數量掛鉤，還有助於降低整體醫療保健成本。

全球腫瘤消融市場促進因素

全球腫瘤消融市場預計將在先進腫瘤消融技術需求不斷成長的推動下實現顯著成長。外科醫師和患者越來越傾向於選擇微創手術，因為微創手術具有許多優勢，例如恢復速度更快、患者舒適度更高、術後恢復時間更短。這種偏好的轉變凸顯了腫瘤學領域技術和調查方法的進步，使這些手術更容易獲得且更具吸引力。人們對這些優勢的認知不斷提高，有望促進創新消融技術的應用，擴大這些治療方法在有效癌症治療中的應用範圍，並增強市場動態。

限制全球腫瘤消融市場發展的因素

全球癌症消融市場面臨許多挑戰，可能阻礙其成長。隨著腫瘤消融療法被公認為治療方法多種固態器官癌症的有效方法，手術的複雜性也可能隨之增加。常見的併發症包括出血和目標器官損傷，這些都是該療法常見的不利事件。這些併發症會帶來重大風險，並可能使患者和醫療機構對消融療法望而卻步。因此，這些手術的潛在副作用可能會成為阻礙腫瘤治療領域市場發展的障礙。

全球腫瘤消融市場趨勢

在全球癌症消融市場，採用創新技術，特別是冷卻射頻探頭，以提高治療效果和安全性，已成為顯著趨勢。市場參與者日益關注能夠提升精準度、便攜性和成本效益的技術進步，例如高強度聚焦超音波（HIFU）、冷凍消融和先進的影像導引系統等領域的進展。在此背景下，新型冷卻射頻神經消融技術正成為關鍵促進因素，能夠對骶髂關節的神經進行全面消融，進而改善疼痛管理。這項技術與患者照護之間的協同作用，反映了改善治療效果的更廣泛趨勢，預計將推動腫瘤消融市場的顯著成長。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術分析
• 監管分析
• 專利分析
• 案例研究

全球腫瘤消融市場規模（依消融類型及複合年成長率分類）（2026-2033 年）

• 射頻消融術（RFA）
• 微波消融術（MWA）
• 雷射消熔
• 冷凍消融術
• 不可逆電穿孔（IRE）
• 高強度聚焦超音波（HIFU）
• 其他

全球腫瘤消融市場規模（按手術類型和複合年成長率分類）（2026-2033 年）

• 微創消融術
• 外科消融術

全球腫瘤消融市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 肝癌
• 肺癌
• 腎癌
• 乳癌
• 攝護腺癌
• 骨癌
• 其他

全球腫瘤消融市場規模（按最終用戶和複合年成長率分類）（2026-2033 年）

• 醫院
• 癌症研究所
• 專科診所
• 門診手術中心（ASC）

全球腫瘤消融市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Angiodynamics（Covidien）（US）
• Boston Scientific Corporation（US）
• Medtronic Plc（US）
• Ethicon, Inc.（US）
• Galil Medical Inc.（US）
• Misonix Inc.（US）
• HealthTronics（US）
• Mermaid Medical（Denmark）
• Theraclion（France）
• Chongqing Haifu Medical Technology Co., Ltd.（China）
• HS Hospital Service SPA（Italy）
• Hologic, Inc.（US）
• Varian Medical Systems（US）
• Cook Medical（US）
• LeVeen Medical（US）
• Integra LifeSciences（US）
• MedWaves, Inc.（US）
• Sanarus Technologies, Inc.（US）
• Bovie Medical Corporation（US）
• ThermoLife（US）

結論與建議

Global Oncology Ablation Market size was valued at USD 1.5 Billion in 2024 and is poised to grow from USD 1.7 Billion in 2025 to USD 4.72 Billion by 2033, growing at a CAGR of 13.6% during the forecast period (2026-2033).

The global oncology ablation market is witnessing robust growth driven by an increasing demand for safer treatment options alongside a significant rise in cancer incidence, particularly in low-income countries. While high-income regions face a 41% increase, emerging markets may see over 80% growth in new cancer cases. This expansion is fueled by the availability of various therapeutic approaches and a preference for minimally invasive and non-invasive treatments. Surgeons and patients are increasingly favoring advanced tumor ablation techniques due to advantages such as quicker recovery and enhanced patient comfort, leading to a shift from conventional therapies. Furthermore, outpatient procedures associated with advanced tumor ablation options not only serve as the preferred choice for smaller tumors but also reduce overall healthcare costs, linking the procedure volume to annual cancer screening rates.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oncology Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oncology Ablation Market Segments Analysis

Global Oncology Ablation Market is segmented by Type of Ablation, Procedure Type, Application, End User and region. Based on Type of Ablation, the market is segmented into Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Laser Ablation, Cryoablation, Irreversible Electroporation (IRE), High-Intensity Focused Ultrasound (HIFU) and Others. Based on Procedure Type, the market is segmented into Minimally Invasive Ablation and Surgical Ablation. Based on Application, the market is segmented into Liver Cancer, Lung Cancer, Kidney Cancer, Breast Cancer, Prostate Cancer, Bone Cancer and Others. Based on End User, the market is segmented into Hospitals, Cancer Research Institutes, Specialty Clinics and Ambulatory Surgical Centers (ASCs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oncology Ablation Market

The Global Oncology Ablation market is expected to see significant growth driven by the rising demand for advanced tumor ablation techniques. Surgeons and patients are increasingly favoring minimally invasive procedures, which offer numerous benefits such as rapid recovery, enhanced patient comfort, and reduced downtime. This shift in preference highlights the advancements in technology and methodology within the oncology sector, making these procedures more accessible and appealing. As awareness of these benefits spreads, the inclination towards utilizing innovative ablation methods is likely to enhance market dynamics and expand the reach of treatments aimed at effectively managing cancer.

Restraints in the Global Oncology Ablation Market

The Global Oncology Ablation market faces several challenges that may inhibit its growth. As tumor ablation therapy gains traction as a viable treatment method for various solid organ cancers, the complexity of procedures may escalate. Common complications include blood loss and damage to the target organ, which are frequent adverse effects associated with these treatments. Such complications pose significant risks and can discourage patients and healthcare providers from opting for ablation therapies. Consequently, the potential side effects related to these procedures may create obstacles that could hinder overall market advancement and acceptance in the oncology treatment landscape.

Market Trends of the Global Oncology Ablation Market

The global oncology ablation market is witnessing a notable trend towards the adoption of innovative technologies, particularly cooled radiofrequency probes, which are enhancing treatment efficacy and safety. Market players are increasingly focusing on advancements that boost accuracy, portability, and cost-effectiveness, exemplified by developments in high-intensity focused ultrasound (HIFU), cryoablation, and sophisticated image-guided systems. Among these, the novel cooled radiofrequency denervation technique is emerging as a key driver, enabling comprehensive denervation of the sacroiliac joint, thus improving pain management. This synergy of technology and patient care is expected to propel significant growth within the oncology ablation market, reflecting a broader trend towards improved therapeutic outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies

Global Oncology Ablation Market Size by Type of Ablation & CAGR (2026-2033)

• Market Overview
• Radiofrequency Ablation (RFA)
• Microwave Ablation (MWA)
• Laser Ablation
• Cryoablation
• Irreversible Electroporation (IRE)
• High-Intensity Focused Ultrasound (HIFU)
• Others

Global Oncology Ablation Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Minimally Invasive Ablation
• Surgical Ablation

Global Oncology Ablation Market Size by Application & CAGR (2026-2033)

• Market Overview
• Liver Cancer
• Lung Cancer
• Kidney Cancer
• Breast Cancer
• Prostate Cancer
• Bone Cancer
• Others

Global Oncology Ablation Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cancer Research Institutes
• Specialty Clinics
• Ambulatory Surgical Centers (ASCs)

Global Oncology Ablation Market Size & CAGR (2026-2033)

• North America (Type of Ablation, Procedure Type, Application, End User)
  • US
  • Canada
• Europe (Type of Ablation, Procedure Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type of Ablation, Procedure Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type of Ablation, Procedure Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type of Ablation, Procedure Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Angiodynamics (Covidien) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ethicon, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galil Medical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Misonix Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HealthTronics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mermaid Medical (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theraclion (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chongqing Haifu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HS Hospital Service S.P.A (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LeVeen Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedWaves, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanarus Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bovie Medical Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ThermoLife (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations